CN1069197C - 含地红霉素的药用制剂 - Google Patents

含地红霉素的药用制剂 Download PDF

Info

Publication number
CN1069197C
CN1069197C CN92103161A CN92103161A CN1069197C CN 1069197 C CN1069197 C CN 1069197C CN 92103161 A CN92103161 A CN 92103161A CN 92103161 A CN92103161 A CN 92103161A CN 1069197 C CN1069197 C CN 1069197C
Authority
CN
China
Prior art keywords
dirithromycin
tablet
solid
water
pharmaceutical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN92103161A
Other languages
English (en)
Chinese (zh)
Other versions
CN1066186A (zh
Inventor
J·M·格林
H·M·汉金斯
G·A·史蒂文森
D·D·沃思
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN1066186A publication Critical patent/CN1066186A/zh
Application granted granted Critical
Publication of CN1069197C publication Critical patent/CN1069197C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CN92103161A 1991-04-29 1992-04-27 含地红霉素的药用制剂 Expired - Fee Related CN1069197C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29
US692,842 1991-04-29

Publications (2)

Publication Number Publication Date
CN1066186A CN1066186A (zh) 1992-11-18
CN1069197C true CN1069197C (zh) 2001-08-08

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
CN92103161A Expired - Fee Related CN1069197C (zh) 1991-04-29 1992-04-27 含地红霉素的药用制剂
CN92103160A Expired - Fee Related CN1030611C (zh) 1991-04-29 1992-04-27 形式ii地红霉素的制备方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN92103160A Expired - Fee Related CN1030611C (zh) 1991-04-29 1992-04-27 形式ii地红霉素的制备方法

Country Status (27)

Country Link
EP (2) EP0511800B1 (enExample)
JP (2) JP3333545B2 (enExample)
KR (2) KR100194307B1 (enExample)
CN (2) CN1069197C (enExample)
AT (2) ATE138924T1 (enExample)
AU (2) AU655978B2 (enExample)
BR (2) BR9201541A (enExample)
CA (2) CA2067275C (enExample)
CY (2) CY1946A (enExample)
CZ (2) CZ282021B6 (enExample)
DE (2) DE69214710T2 (enExample)
DK (2) DK0511800T3 (enExample)
ES (2) ES2093779T3 (enExample)
FI (2) FI101795B (enExample)
GR (2) GR3020439T3 (enExample)
HK (2) HK153696A (enExample)
HU (2) HU213613B (enExample)
IE (2) IE76296B1 (enExample)
IL (2) IL101705A (enExample)
MX (2) MX9201944A (enExample)
MY (2) MY109498A (enExample)
NO (2) NO180450C (enExample)
NZ (2) NZ242506A (enExample)
RU (2) RU2070203C1 (enExample)
TW (2) TW315371B (enExample)
YU (2) YU44492A (enExample)
ZA (2) ZA922777B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (enExample) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
EP0915899B1 (en) * 1996-07-29 2004-08-04 Abbott Laboratories Preparation of crystal form ii of clarithromycin
PL332503A1 (en) * 1996-09-24 1999-09-13 Lilly Co Eli Coated particles containing preparation
RU2147234C1 (ru) * 1999-03-09 2000-04-10 Жемчугов Владислав Евгеньевич Препарат для профилактики и лечения особо опасных инфекционных заболеваний
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
RU2212242C1 (ru) * 2001-12-24 2003-09-20 Закрытое акционерное общество "Брынцалов-А" Антибиотик сумазид
KR101120483B1 (ko) * 2006-12-05 2012-02-29 브리스톨-마이어즈 스퀴브 컴페니 모틸라이드 다형체
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048306A (en) * 1975-04-07 1977-09-13 Boehringer Ingelheim Gmbh Aldehyde-erythromycylamine condensation products
US4743593A (en) * 1984-12-08 1988-05-10 Beecham Group P.L.C. 9,11-O-methylene derivatives of 9-dihydroerythromycin
US4755385A (en) * 1985-07-10 1988-07-05 Dr. Karl Thomae, Gmbh Oral pharmaceutical preparations containing 9-deoxo-11-deoxy-9,11-[imino[2-(2-methoxyethoxy)-ethylidene]-oxy]-(9S)-erythromycin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048306A (en) * 1975-04-07 1977-09-13 Boehringer Ingelheim Gmbh Aldehyde-erythromycylamine condensation products
US4743593A (en) * 1984-12-08 1988-05-10 Beecham Group P.L.C. 9,11-O-methylene derivatives of 9-dihydroerythromycin
US4755385A (en) * 1985-07-10 1988-07-05 Dr. Karl Thomae, Gmbh Oral pharmaceutical preparations containing 9-deoxo-11-deoxy-9,11-[imino[2-(2-methoxyethoxy)-ethylidene]-oxy]-(9S)-erythromycin

Also Published As

Publication number Publication date
EP0511799B1 (en) 1996-06-05
FI921877A0 (fi) 1992-04-27
NO921616D0 (no) 1992-04-27
YU44392A (sh) 1994-12-28
MY114226A (en) 2002-09-30
FI921876A0 (fi) 1992-04-27
MY109498A (en) 1997-02-28
KR920019365A (ko) 1992-11-19
DK0511800T3 (da) 1997-04-21
AU655978B2 (en) 1995-01-19
CS127792A3 (en) 1992-11-18
AU1525792A (en) 1992-11-05
KR100194307B1 (ko) 1999-06-15
ATE144425T1 (de) 1996-11-15
CY1975A (en) 1997-09-05
NO180450B (no) 1997-01-13
NZ242506A (en) 1993-09-27
CA2067275C (en) 2002-11-26
HU213613B (en) 1997-08-28
IL101704A0 (en) 1992-12-30
CZ282218B6 (cs) 1997-06-11
TW216399B (enExample) 1993-11-21
FI101795B1 (fi) 1998-08-31
JP3135672B2 (ja) 2001-02-19
ES2093779T3 (es) 1997-01-01
FI921877L (fi) 1992-10-30
CA2067274C (en) 2002-10-15
ES2088098T3 (es) 1996-08-01
JP3333545B2 (ja) 2002-10-15
DE69211220D1 (de) 1996-07-11
EP0511800B1 (en) 1996-10-23
EP0511799A1 (en) 1992-11-04
FI101795B (fi) 1998-08-31
NO179504C (no) 1996-10-23
HU9201398D0 (en) 1992-07-28
JPH05117289A (ja) 1993-05-14
DE69214710D1 (de) 1996-11-28
HU9203168D0 (en) 1992-12-28
HUT63956A (en) 1993-11-29
GR3021706T3 (en) 1997-02-28
MX9201944A (es) 1992-11-01
CZ282021B6 (cs) 1997-04-16
CY1946A (en) 1992-04-27
IE921345A1 (en) 1992-11-04
HK215096A (en) 1996-12-13
NO921617D0 (no) 1992-04-27
NO180450C (no) 1997-04-23
DE69211220T2 (de) 1996-11-07
NO179504B (no) 1996-07-15
YU44492A (sh) 1994-06-24
BR9201541A (pt) 1992-12-01
AU1525592A (en) 1992-11-05
IE76296B1 (en) 1997-10-08
HK153696A (en) 1996-08-16
NZ242505A (en) 1993-06-25
AU646734B2 (en) 1994-03-03
NO921617L (no) 1992-10-30
CA2067275A1 (en) 1992-10-30
HU215917B (hu) 1999-03-29
ZA922777B (en) 1993-10-15
ZA922776B (en) 1993-10-15
IE921346A1 (en) 1992-11-04
CN1030611C (zh) 1996-01-03
GR3020439T3 (en) 1996-10-31
BR9201540A (pt) 1992-12-01
JPH05117154A (ja) 1993-05-14
IL101704A (en) 1998-02-22
IL101705A0 (en) 1992-12-30
FI921876A7 (fi) 1992-10-30
CN1066270A (zh) 1992-11-18
MX9201946A (es) 1992-11-01
RU2045953C1 (ru) 1995-10-20
NO921616L (no) 1992-10-30
KR100193742B1 (ko) 1999-06-15
IL101705A (en) 1996-01-31
RU2070203C1 (ru) 1996-12-10
IE74885B1 (en) 1997-08-13
CN1066186A (zh) 1992-11-18
FI921876L (fi) 1992-10-30
CS127692A3 (en) 1992-11-18
CA2067274A1 (en) 1992-10-30
DE69214710T2 (de) 1997-03-13
EP0511800A1 (en) 1992-11-04
ATE138924T1 (de) 1996-06-15
KR920019364A (ko) 1992-11-19
DK0511799T3 (da) 1996-06-24
HUT62595A (en) 1993-05-28
TW315371B (enExample) 1997-09-11

Similar Documents

Publication Publication Date Title
CN1163231C (zh) 用于口服的美洛西肯的盖伦制剂
CN1105705C (zh) 一种特定物理形态的杂环酰胺衍生物的制备方法
CN1179102A (zh) 2－甲基－噻吩并－苯并二氮杂䓬口服制剂
CN1303390A (zh) 抗病毒苯并咪唑化合物的新晶体形式
CN1613858A (zh) 利福昔明的多晶形，它们的制备方法及其在药物制剂中的应用
CN1069197C (zh) 含地红霉素的药用制剂
CN1638771A (zh) 3－[(2－{[4－(己氧羰基氨基－亚氨基－甲基)－苯基氨基]－甲基}－1－甲基－1h－苯并咪唑－5－羰基）－吡啶－2－基－氨基]－丙酸乙酯及其盐的口服施用的投药剂型
CN1181064C (zh) 结晶形式的n－(4－三氟甲基苯基)－5－甲基异噁唑－4－甲酰胺的制备方法
WO2011095059A1 (zh) 达沙替尼多晶型物及其制备方法和药物组合物
CN101633658A (zh) 磷酸西他列汀晶形及其制备方法
AU2012324013A1 (en) Pharmaceutical compositions of selective androgen receptor modulators and methods of use thereof
JP2002513760A (ja) パロキセチン固体分散体を製造するための水系方法
CN1290843C (zh) 4－[2－[4－[1－(2－乙氧基乙基)－1H－苯并咪唑－2－基]－1－哌啶基]乙基]－α,α－二甲基苯乙酸的多晶型物
US7544805B2 (en) Stable amorphous forms of montelukast sodium
CN1230883A (zh) 包衣颗粒制剂
CN1032793A (zh) 结晶态的β-内酰胺水合物
CN1898211A (zh) 喹啉化合物的晶形及其生产方法
CN1812968A (zh) 4－[6－乙酰基－3－[3－(4－乙酰基－3－羟基－2－丙基苯硫基)丙基]－2－丙基苯氧基]丁酸的多晶型物a
US7351710B2 (en) Preparation of amorphous form of indiplon
CN1434702A (zh) 新的帕伐他丁钠形式
CN1055739A (zh) 半水合物
AU2009321385A1 (en) Novel processes and pure polymorphs
CN1109745A (zh) 含布洛芬的固体组合物
CN1314888A (zh) 奥沙奈丹的晶型
CN1034929A (zh) 结晶β-内酰胺溶剂化物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee